Disc Medicine Statistics
Share Statistics
Disc Medicine has 29.76M shares outstanding. The number of shares has increased by 20.57% in one year.
| Shares Outstanding | 29.76M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.11% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 15.64M |
| Failed to Deliver (FTD) Shares | 24 |
| FTD / Avg. Volume | 0.01% |
Short Selling Information
The latest short interest is 1.66M, so 5.58% of the outstanding shares have been sold short.
| Short Interest | 1.66M |
| Short % of Shares Out | 5.58% |
| Short % of Float | 10.62% |
| Short Ratio (days to cover) | 6.4 |
Valuation Ratios
The PE ratio is -16.86 and the forward PE ratio is -12.03.
| PE Ratio | -16.86 |
| Forward PE | -12.03 |
| PS Ratio | 0 |
| Forward PS | 637.8 |
| PB Ratio | 3.73 |
| P/FCF Ratio | -17.52 |
| PEG Ratio | n/a |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Disc Medicine Inc..
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 17.06, with a Debt / Equity ratio of 0.
| Current Ratio | 17.06 |
| Quick Ratio | 17.06 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0 |
| Cash Flow / Debt | 0 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -0.22% and return on capital (ROIC) is -26.28%.
| Return on Equity (ROE) | -0.22% |
| Return on Assets (ROA) | -0.21% |
| Return on Capital (ROIC) | -26.28% |
| Revenue Per Employee | 0 |
| Profits Per Employee | -932.06K |
| Employee Count | 82 |
| Asset Turnover | 0 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 99.00K |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by 10.39% in the last 52 weeks. The beta is 0.18, so Disc Medicine 's price volatility has been higher than the market average.
| Beta | 0.18 |
| 52-Week Price Change | 10.39% |
| 50-Day Moving Average | 60.81 |
| 200-Day Moving Average | 47.02 |
| Relative Strength Index (RSI) | 51.79 |
| Average Volume (20 Days) | 309.58K |
Income Statement
| Revenue | n/a |
| Gross Profit | -100.00K |
| Operating Income | -91.13M |
| Net Income | -76.43M |
| EBITDA | -91.03M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -3.43 |
Balance Sheet
The company has 360.38M in cash and 2.10M in debt, giving a net cash position of 358.28M.
| Cash & Cash Equivalents | 360.38M |
| Total Debt | 2.10M |
| Net Cash | 358.28M |
| Retained Earnings | -188.65M |
| Total Assets | 495.14M |
| Working Capital | 467.68M |
Cash Flow
In the last 12 months, operating cash flow was -73.46M and capital expenditures -89.00K, giving a free cash flow of -73.55M.
| Operating Cash Flow | -73.46M |
| Capital Expenditures | -89.00K |
| Free Cash Flow | -73.55M |
| FCF Per Share | -3.3 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
IRON does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -5.36% |
| FCF Yield | -3.87% |
Analyst Forecast
The average price target for IRON is $72.5, which is 13.4% higher than the current price. The consensus rating is "Buy".
| Price Target | $72.5 |
| Price Target Difference | 13.4% |
| Analyst Consensus | Buy |
| Analyst Count | 10 |
Stock Splits
The last stock split was on Dec 30, 2022. It was a backward split with a ratio of 1:10.
| Last Split Date | Dec 30, 2022 |
| Split Type | backward |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | 42.24 |
| Piotroski F-Score | 1 |